Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
7.625 USD | -1.74% | +10.10% | +29.76% |
05-07 | Cogent Biosciences Q1 Loss Widens | MT |
05-07 | Cogent Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.76% | 742M | |
+4.31% | 106B | |
+6.84% | 23.47B | |
-14.43% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.30% | 16.78B | |
+7.31% | 14.41B | |
+38.73% | 12.86B | |
+323.91% | 8.78B |
- Stock Market
- Equities
- COGT Stock
- News Cogent Biosciences, Inc.
- Baird Downgrades Cogent Biosciences to Neutral From Outperform, Adjusts Price Target to $8 From $14